Another Heartbreak in the Fight Against Dementia: Alector's Flagship Drug Fails Late-Stage Trial
Gilead Halts HIV Drug Price Hikes Amidst Growing Scrutiny and Public Pressure
Is the Healthcare Sector Primed for a Powerful Rebound?
Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership
A Landmark Clash: India's Supreme Court Navigates Life-Saving SMA Drugs, Patents, and Public Access
Beyond COVID: mRNA Vaccines Unleash a New Weapon Against Cancer's Toughest Foes
A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025
A New Dawn for Breast Cancer Treatment: Roche's Gedatolisib and Giredestrant Combination Shows Promise
Nektar Therapeutics Stock Soars Amid Intense Takeover Speculation
FDA Unleashes Game-Changing Incentive: Priority Review Vouchers Set to Revolutionize Drug Development
Roche's Bold Leap: Pioneering Direct Patient Engagement for Enhanced Care
The Revolving Door: Ex-FDA Regulators Find New Homes at Pharma Giants Like Eli Lilly
Cidara Therapeutics Skyrockets as Morgan Stanley Elevates Rating to 'Overweight'
Omeros Stock Skyrockets: Novo Nordisk Seals Massive $2.1 Billion Rare Disease Drug Deal
Urgent Health Alert: Abbott Warns of Dangerous Counterfeit Amoxyclav Batches Circulating in India
Skyrocketing Health Costs: How Pricey New Drugs Are Driving an 8.5% Premium Hike in 2026
Abbott Labs Faces Mixed Fortunes in Q3: Revenue Missed, But Earnings & Future Outlook Impress
North Carolina's Biotech Boom: Powering the Future of Medicine Through Advanced Manufacturing
Telangana's Landmark Move: Mandatory Testing for Deadly Contaminants in All Syrups to Secure Public Health
Takeda and Nabla Bio Forge $1 Billion Alliance to Revolutionize Antibody Design with AI
The Silent Threat Below the Surface: How Drug Cocktails in Our Waterways Fuel a Global Health Crisis
Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape
Johnson & Johnson Soars: Q3 Earnings Crush Expectations, Full-Year Forecast Skyrockets!
Johnson & Johnson's Bold Orthopedics Spin-Off: A New Era of Growth and Value Unveiled
Johnson & Johnson Soars: Beating Q3 Expectations and Raising Full-Year Outlook
J&J's Q3 Rollercoaster: Stock Dip, MedTech Hopes, and Tariff Tangles!
Under Siege: Whistleblowers Unmask Political Pressures Threatening FDA's Scientific Soul
Urgent Global Health Alert: WHO Flags Contaminated Cough Syrups in India
The Production Predicament: How Manufacturing Woes Threaten Novo Nordisk's Blockbuster Drugs
The Biotech Bonanza: Unearthing Tomorrow's Investment Gems in a Volatile Market
Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs
AstraZeneca's Landmark Deal: Lowering Drug Prices for Medicaid Under Trump Administration Agreement
Revolutionizing Healthcare: Trump's Bold Stance on Lowering Prescription Drug Costs
President Trump's Landmark Initiative to Tackle Skyrocketing Prescription Drug Costs
Novo Nordisk Shifts Focus: Why the Cell Therapy Unit is Closing Its Doors
Rubicon Research IPO Draws Strong Investor Interest, Nearing Full Subscription on Day 2
The Silent Storm: Why Our Conversations About Antibiotic Resistance Need a Radical Overhaul
Boston-Cambridge: The Unrivaled Epicenter of Global Biotech Innovation
Monopar's Breakthrough in Wilson Disease: A New Dawn with AstraZeneca's Shadow
Biohaven's Breakthrough Bid: Navigating FDA Flexibility for Spinocerebellar Ataxia's Future
Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal
Unlocking Cures: The Pharmaceutical Industry's Toughest Battle in the Global South
A Deadly Divide: WHO Unmasks Critical Flaw in India's Domestic Cough Syrup Testing